Patents by Inventor Qiaojuan Su

Qiaojuan Su has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • System and method for scientific information knowledge management
    Publication number: 20070162411
    Abstract: The present invention relates to methods, systems and apparatus for capturing, integrating, organizing, navigating and querying large-scale data from high-throughput biological and chemical assay platforms. It provides a highly efficient meta-analysis infrastructure for performing research queries across a large number of studies and experiments from different biological and chemical assays, data types and organisms, as well as systems to build and add to such an infrastructure.
    Type: Application
    Filed: December 18, 2006
    Publication date: July 12, 2007
    Inventors: Ilya Kupershmidt, Qiaojuan Su, Francois Andry
  • Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
    Publication number: 20050059087
    Abstract: The present invention relates to novel antibodies, particularly antibodies directed against deletion mutants of epidermal growth factor receptor and particularly to the type III deletion mutant, EGFRvIII. The invention also relates to human monoclonal antibodies directed against deletion mutants of epidermal growth factor receptor and particularly to EGFRvIII. Diagnostic and therapeutic formulations of such antibodies, and immunoconjugates thereof, are also provided.
    Type: Application
    Filed: June 25, 2004
    Publication date: March 17, 2005
    Inventors: Richard Weber, Xiao Feng, Orit Foord, Larry Green, Jean Gudas, Bruce Keyt, Ying Liu, Palaniswami Rathanaswami, Robert Raya, Xiao Yang, Jose Corvalan, Ian Foltz, Xiao-Chi Jia, Jaspal Kang, Chadwick King, Scott Klakamp, Qiaojuan Su
  • Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
    Publication number: 20050053608
    Abstract: The present invention relates to novel antibodies, particularly antibodies directed against deletion mutants of epidermal growth factor receptor and particularly to the type III deletion mutant, EGFRvIII. The invention also relates to human monoclonal antibodies directed against deletion mutants of epidermal growth factor receptor and particularly to EGFRvIII. Diagnostic and therapeutic formulations of such antibodies, and immunoconjugates thereof, are also provided.
    Type: Application
    Filed: June 25, 2004
    Publication date: March 10, 2005
    Inventors: Richard Weber, Xiao Feng, Orit Foord, Larry Green, Jean Gudas, Bruce Keyt, Ying Liu, Palaniswami Rathanaswami, Robert Raya, Xiao Yang, Jose Corvalan, Ian Foltz, Xiao-Chi Jia, Jaspal Kang, Chadwick King, Scott Klakamp, Qiaojuan Su
  • Antibodies directed to tumor necrosis factor and uses thereof
    Publication number: 20050049402
    Abstract: Antibodies directed to the antigen TNF? and uses of such antibodies. In particular, fully human monoclonal antibodies directed to the antigen TNF?. Nucleotide sequences encoding, and amino acid sequences comprising, heavy and light chain immunoglobulin molecules, particularly sequences corresponding to contiguous heavy and light chain sequences spanning the framework regions and/or complementarity determining regions (CDR's), specifically from FR1 through FR4 or CDR1 through CDR3. Hybridomas or other cell lines expressing such immunoglobulin molecules and monoclonal antibodies.
    Type: Application
    Filed: December 2, 2003
    Publication date: March 3, 2005
    Inventors: John Babcook, Jaspal Kang, Orit Foord, Larry Green, Xiao Feng, Scott Klakamp, Mary Haak-Frendscho, Palaniswami Rathanaswami, Craig Pigott, Meina Liang, Yen-Wah Lee, Kathy Manchulencko, Raffaella Faggioni, Giorgio Senaldi, Qiaojuan Su